Healthcare ServicesCompany
Circassia Pharmaceuticals M&A Summary
Circassia Pharmaceuticals has acquired 3 companies. A total of 2 acquisitions came from private equity firms.
Circassia Pharmaceuticals’ largest acquisition to date was in 2015, when it acquired Aerocrine AB for $211M. Circassia Pharmaceuticals has acquired in 2 countries. The Company’s most targeted sectors include healthcare services (50%) and medical products (50%).
Circassia Pharmaceuticals Business Overview
Where is Circassia Pharmaceuticals headquartered?
Circassia Pharmaceuticals is headquartered in Oxford, United Kingdom.
What is Circassia Pharmaceuticals’ revenue?
Circassia Pharmaceuticals disclosed revenue of 24M EUR for 2020 and 62M EUR for 2019.
How many employees does Circassia Pharmaceuticals have?
Circassia Pharmaceuticals has 162 employees.
What sector is Circassia Pharmaceuticals in?
Circassia Pharmaceuticals is a healthcare services company.
When was Circassia Pharmaceuticals founded?
Circassia Pharmaceuticals was founded in 2006.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2
Unlimited Searches
